Learn More
BACKGROUND Large-scale, prospective studies of infectious intestinal disease (IID) in developed countries are uncommon. Two studies of IID incidence and etiology have been conducted in the United(More)
3668 Background: Intraperitoneal (IP) FU/FA may confer a survival advantage when added to IV adjuvant therapy in patients (pts) with colorectal cancer (Br J Cancer 77:1349, 1998). The aims of this(More)
  • 1